RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$35.73
+2.82 (+8.57%)
Open$33.65
Previous Close$32.91
Day High$36.53
Day Low$33.64
52W High$52.24
52W Low$18.14
Volume—
Avg Volume363.7K
Market Cap608.90M
P/E Ratio1.67
EPS$18.43
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+51.4% upside
Current
$35.73
$35.73
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 285.02M | 211.47M | 385.25M |
| Net Income | 355.47M | 237.37M | -63,461,041 |
| Profit Margin | 124.7% | 118.5% | -16.5% |
| EBITDA | 123.86M | 87.30M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +34.8% | +34.8% | +12.7% |
| Debt/Equity | 0.13 | 0.13 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |